ZARXIO 300 MCG/0.5 ML SYRINGE

filgrastim-sndz
$533.3970per ML

Strength

300 ug/.5mL

Manufacturer

Sandoz Inc.

NDC

61314031801

Classification

Brand Biologic

Dosage Form

INJECTION, SOLUTION

Route

INTRAVENOUS; SUBCUTANEOUS

Last Updated

4/22/2026

Active Ingredients

FILGRASTIM

Approval Type

Biologic (BLA)

FDA Application

BLA125553

On Market Since

3/6/2015

Pharmacological Classes

Granulocyte Colony-Stimulating Factor
Increased Myeloid Cell Production
Leukocyte Growth Factor

Price History

1W

0.0%

1M

-0.1%

3M

-0.1%

6M

+0.0%

1Y

+0.6%

3Y

N/A

5Y

N/A

All

+0.6%

Generic Alternatives

Save up to 1%

1 alternative • Same active ingredient